Stock listing
NASDAQ:PSTX Poseida Therapeutics Inc Stock
Follow Poseida Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PSTX
$9.50 USD
Close on Jan 7, 2025 · No longer trades
- Lowest – highest close
- $1.62 – $16.25 USDSince Jul 10, 2020 · lowest Aug 3, 2023 · highest Jul 20, 2020
Delisted NASDAQ:PSTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PSTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Poseida Therapeutics Inc on 6ix
- Decks
- 7 decks · latest Nov 14, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (November 2024) | Investor day | 73 slides | Nov 14, 2024 |
| Investor Day (April 2024) | Investor day | 87 slides | Apr 17, 2024 |
| Investor Day (February 2023) | Investor day | 145 slides | Feb 22, 2023 |
| Investor Presentation (August 2022) | Investor deck | 16 slides | Aug 3, 2022 |
| Investor Day (February 2022) | Investor day | 180 slides | Feb 23, 2022 |
| Technical Presentation (February 2022) | Technical | 6 slides | Feb 17, 2022 |
| Technical Presentation (August 2021) | Technical | 16 slides | Aug 31, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Schmid Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past) | Director · Jul 9, 2020 – Jan 8, 2025 · Past |
| Charles Baum Other companies: Acrivon Therapeutics, Inc. (Director · Since at least Jun 22, 2023); PMV Pharmaceuticals, Inc. (Director · Since at least Apr 1, 2021); Tango Therapeutics, Inc. (Director · Sep 2, 2020 – Sep 2, 2020 · Past); Immunomedics Inc (Director · Feb 23, 2019 – Oct 23, 2020 · Past) | Director · May 16, 2022 – Jan 8, 2025 · Past |
| David Hirsch Other companies: Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Molecular Templates Inc (Director · Aug 1, 2017 – Jun 3, 2022 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – May 20, 2020 · Past) | Director · Jul 9, 2020 – Jul 23, 2021 · Past |
| Rafael G. Amado Other companies: Zai Lab Ltd. (President, Head of Global Research and Development · Since at least Dec 30, 2022); Allogene Therapeutics, Inc. (EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past) | Director · Apr 13, 2023 – Jan 8, 2025 · Past |
| Sean Murphy Other companies: TriSalus Life Sciences, Inc. (Director · Since at least Aug 10, 2023); Radius Health, Inc. (Director · Aug 10, 2020 – Aug 15, 2022 · Past); Novan Inc (Director · Sep 20, 2016 – Jun 4, 2018 · Past) | Director · Jul 9, 2020 – Jul 14, 2020 · Past |
| Syed Ali-aamir Rizvi Other companies: Rocket Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Sep 15, 2025); Caribou Biosciences, Inc. (Chief Medical Officer · Jan 18, 2022 – Feb 21, 2023 · Past) | Chief Medical Officer · Apr 1, 2024 – Jan 8, 2025 · Past |
| Harry J Leonhardt Other companies: Halozyme Therapeutics, Inc. (SVP, GC · Apr 13, 2016 – Apr 13, 2019 · Past) | GC & Chief Compliance Officer · Sep 15, 2020 – Jan 8, 2025 · Past |
| Marcea Bland Lloyd Other companies: Amylin Pharmaceuticals LLC (SVP, Chief Administrative Offi · Mar 1, 2011 – Feb 8, 2012 · Past) | Director · Jul 9, 2020 – Jan 8, 2025 · Past |
| Brent Warner | President, Gene Therapy · Feb 21, 2022 – Mar 1, 2024 · Past |
| Johanna Mylet | Chief Financial Officer · Jul 9, 2020 – Jan 8, 2025 · Past |
All 13 people
| Person | Seat |
|---|---|
| Kerry D Ingalls | Chief Operating Officer · Jul 9, 2020 – Mar 16, 2022 · Past |
| Luke Corning | Director · Dec 16, 2020 – Jan 8, 2025 · Past |
| Mark J Gergen | President and CEO, Director · Feb 1, 2023 – Jan 8, 2025 · Past |
Log in to ask 6ix AI your own questions about Poseida Therapeutics Inc.